Thomas Willemsen, Tessa Therapeutics CEO

Flush with $126M raise, Tes­sa Ther­a­peu­tics woos new CEO from Take­da

Af­ter some repo­si­tion­ing — and a $126 mil­lion fi­nanc­ing round to take it down that di­rec­tion — Sin­ga­pore’s Tes­sa Ther­a­peu­tics has found a new cap­tain to steer the ship.

Thomas Willem­sen is jump­ing from Take­da, where he was most re­cent­ly SVP, Asia-Pa­cif­ic, to spear­head Tes­sa’s dri­ve to de­vel­op new CAR-T ther­a­pies, in­clud­ing both au­tol­o­gous and off-the-shelf ones.

As pres­i­dent and CEO, Willem­sen will be in charge of “cor­po­rate, busi­ness and de­vel­op­ment strat­e­gy,” the com­pa­ny added.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.